Study Purpose: To formulate recommendations about clinical management of liver involvement
in hereditary hemorrhagic telangiectasia (HHT), using a formal consensus development …

Hereditary haemorrhagic telangiectasia (HHT) is a rare autosomal dominant disorder,
characterised by the presence of vascular malformations. The pulmonary vascular complications …

Hereditary Hemorrhagic Telangiectasia (HHT) is easily recognized in individuals displaying
the classical triad of epistaxis, telangiectasia, and a suitable family history, but the disease is …

Objective Rare diseases may be difficult to study through conventional research methods,
but are amenable to study through certain uncommonly used designs. We sought to explain …

Background HHT is an autosomal dominant disease with an estimated prevalence of at
least 1/5000 which can frequently be complicated by the presence of clinically significant …

Description: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease
with an estimated prevalence of 1 in 5000 that is characterized by the presence of vascular …

Hepatopulmonary syndrome (HPS) is present in 10– 32% of chronic liver disease patients,
carries a poor prognosis and is treatable by liver transplantation (LT). Previous reports have …

Objective To study the clinical characteristics andprognosis of patients with diffuse pulmonary
arteriovenousmalformations (AVMs). Design Retrospective chartreview of all patients (n = …

Juvenile polyposis (JP) and hereditary hemorrhagic telangiectasia (HHT) are clinically distinct
diseases caused by mutations in SMAD4 and BMPR1A (for JP) and endoglin and ALK1 (…

Background Pulmonary arteriovenous malformations (PAVMs) lead to stroke, brain abscess,
and hemorrhage in hereditary hemorrhagic telangiectasia (HHT). The current screening …